SANGEETA MUTNURI
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology HOUSTON, TX NPI 1962790477
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology TX Bayer HealthCare Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$849.34
- Category: General Payments
- Program years: PY2019–2023
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $185.08 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $185.08 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $44.11 | 2 |
| Mallinckrodt Hospital Products Inc. | $39.76 | 1 |
| Amgen Inc. | $32.32 | 1 |
| Aurinia Pharma U.S., Inc. | $18.91 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $18.40 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.06 | 1 |
| Acerta Pharma LLC | $14.52 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1000605105 | Bayer Healthcare Pharmaceuticals Inc. | $19.92 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1000627697 | Bayer Healthcare Pharmaceuticals Inc. | $24.19 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1014612485 | Otsuka America Pharmaceutical, Inc. | $17.06 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1014727027 | AstraZeneca Pharmaceuticals LP | $14.52 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1020672721 | Amgen Inc. | $32.32 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1042865369 | Mallinckrodt Hospital Products Inc. | $39.76 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1057745183 | Aurinia Pharma U.S., Inc. | $18.91 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993481273 | Calliditas Therapeutics US Inc. | $18.40 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.